3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Atrophy

3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide has been researched along with Atrophy in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (66.67)	18.2507
2000's	1 (33.33)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Buhmann, C; Bussopulos, A; Oechsner, M	1
Janssen, AG; Kuiper, MA; Speelman, JD; van Royen, E; Verhoeff, NF; Wolters, EC	1
Arnold, G; Gasser, T; Oertel, WH; Schwarz, J; Tatsch, K	1

Trials

1 trial(s) available for 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Atrophy

Article	Year
[123]IBZM binding predicts dopaminergic responsiveness in patients with parkinsonism and previous dopaminomimetic therapy. Movement disorders : official journal of the Movement Disorder Society, 1997, Volume: 12, Issue:6 Topics: Adult; Aged; Apomorphine; Atrophy; Benzamides; Binding Sites; Cerebral Cortex; Dopamine; Dopamine Agonists; Dopamine Antagonists; Follow-Up Studies; Humans; Levodopa; Magnetic Resonance Imaging; Middle Aged; Parkinson Disease; Predictive Value of Tests; Putamen; Pyrrolidines; Receptors, Dopamine D2; Tomography, Emission-Computed, Single-Photon	1997

Article

Year

[123]IBZM binding predicts dopaminergic responsiveness in patients with parkinsonism and previous dopaminomimetic therapy.

Movement disorders : official journal of the Movement Disorder Society, 1997, Volume: 12, Issue:6

Topics: Adult; Aged; Apomorphine; Atrophy; Benzamides; Binding Sites; Cerebral Cortex; Dopamine; Dopamine Agonists; Dopamine Antagonists; Follow-Up Studies; Humans; Levodopa; Magnetic Resonance Imaging; Middle Aged; Parkinson Disease; Predictive Value of Tests; Putamen; Pyrrolidines; Receptors, Dopamine D2; Tomography, Emission-Computed, Single-Photon

1997

Other Studies

2 other study(ies) available for 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Atrophy

Article	Year
Dopaminergic response in Parkinsonian phenotype of Machado-Joseph disease. Movement disorders : official journal of the Movement Disorder Society, 2003, Volume: 18, Issue:2 Topics: Atrophy; Basal Ganglia; Benzamides; Cerebellum; Contrast Media; Corpus Striatum; Dopamine Agonists; Humans; Machado-Joseph Disease; Magnetic Resonance Imaging; Male; Middle Aged; Occipital Lobe; Parkinsonian Disorders; Phenotype; Pons; Pyrrolidines; Tomography, Emission-Computed, Single-Photon; Treatment Outcome	2003
Multiple system atrophy and progressive supranuclear palsy. Diminished striatal D2 dopamine receptor activity demonstrated by 123I-IBZM single photon emission computed tomography. Archives of neurology, 1993, Volume: 50, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Atrophy; Benzamides; Central Nervous System; Dopamine D2 Receptor Antagonists; Humans; Middle Aged; Parkinson Disease; Pyrrolidines; Receptors, Dopamine D2; Supranuclear Palsy, Progressive; Tomography, Emission-Computed, Single-Photon	1993

Article

Year

Dopaminergic response in Parkinsonian phenotype of Machado-Joseph disease.

Movement disorders : official journal of the Movement Disorder Society, 2003, Volume: 18, Issue:2

Topics: Atrophy; Basal Ganglia; Benzamides; Cerebellum; Contrast Media; Corpus Striatum; Dopamine Agonists; Humans; Machado-Joseph Disease; Magnetic Resonance Imaging; Male; Middle Aged; Occipital Lobe; Parkinsonian Disorders; Phenotype; Pons; Pyrrolidines; Tomography, Emission-Computed, Single-Photon; Treatment Outcome

2003

Multiple system atrophy and progressive supranuclear palsy. Diminished striatal D2 dopamine receptor activity demonstrated by 123I-IBZM single photon emission computed tomography.

Archives of neurology, 1993, Volume: 50, Issue:5

Topics: Adult; Aged; Aged, 80 and over; Atrophy; Benzamides; Central Nervous System; Dopamine D2 Receptor Antagonists; Humans; Middle Aged; Parkinson Disease; Pyrrolidines; Receptors, Dopamine D2; Supranuclear Palsy, Progressive; Tomography, Emission-Computed, Single-Photon

1993